Clinical Studies Medical Research Public Health Patient Care Pharmacology Preventive Medicine Clinical Studies Pharmacology Research Personalized Medicine
It leverages CRISPR/Cas9 disruption of the interferon-γ receptor to boost CAR-T cell durability ahead of planned solid tumor trials.